MSB 3.42% $1.21 mesoblast limited

have patent lawyers on stand -by , page-5

  1. 3,399 Posts.
    lightbulb Created with Sketch. 3005
    dolcevita

    "antibody: would you like to explain why you think that MSB's patent applications will be more open to challenge because of successful FDA trials?"

    I would appreciate you not putting words into my mouth to suit whatever superior stance you are trying to take here. There was not a word in my post to support your assertion of why I think what you say I think? Not even "of" or "to"!

    Then I'm wondering about the thinly veiled superior air to your aggressive "would I like to explain?" - are you a trial lawyer or with the police by any chance?

    But then maybe you just have superior inside knowledge of every root and branch detail of MSB's 60 odd patent suites - which would put me at a disadvantage in a debate with you about their ultimate strength in a dispute situation which might arise once there are 100 companies clamoring for rights to sell their stem cell products.

    To answer your assertion/question, I think I will ignore you - if that's OK with you.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.